Detalhe da pesquisa
1.
PETAL protocol: a phase Ib study of pembrolizumab after transarterial chemoembolization in hepatocellular carcinoma.
Future Oncol
; 19(7): 499-507, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-37097715
2.
Qualification of tumour mutational burden by targeted next-generation sequencing as a biomarker in hepatocellular carcinoma.
Liver Int
; 41(1): 192-203, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33098208
3.
Immunotoxicity from checkpoint inhibitor therapy: clinical features and underlying mechanisms.
Immunology
; 159(2): 167-177, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31646612
4.
Perspectives on the Neoadjuvant Use of Immunotherapy in Hepatocellular Carcinoma.
Hepatology
; 74(1): 483-490, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33369758
5.
Insights into the metastatic cascade through research autopsies.
Trends Cancer
; 9(6): 490-502, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37059687
6.
Integrated phenotyping of the anti-cancer immune response in HIV-associated hepatocellular carcinoma.
JHEP Rep
; 5(7): 100741, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-37274775
7.
Immune Checkpoint Inhibitors for Child-Pugh Class B Advanced Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis.
JAMA Oncol
; 9(10): 1423-1431, 2023 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37615958
8.
Patterns and outcomes of subsequent therapy after immune checkpoint inhibitor discontinuation in HCC.
Hepatol Commun
; 6(7): 1776-1785, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35481940
9.
Combined PD-1/VEGFR Blockade: A New Era of Treatment for Hepatocellular Cancer.
Clin Cancer Res
; 27(4): 908-910, 2021 02 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33328343
10.
Phenotypic Characteristics of the Tumour Microenvironment in Primary and Secondary Hepatocellular Carcinoma.
Cancers (Basel)
; 13(9)2021 Apr 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-33946676
11.
Trans-arterial chemoembolization as a loco-regional inducer of immunogenic cell death in hepatocellular carcinoma: implications for immunotherapy.
J Immunother Cancer
; 9(9)2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34593621
12.
Antacid exposure and immunotherapy outcomes among patients with advanced hepatocellular carcinoma.
Ther Adv Med Oncol
; 13: 17588359211010937, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33995594
13.
Early Antibiotic Exposure Is Not Detrimental to Therapeutic Effect from Immunotherapy in Hepatocellular Carcinoma.
Liver Cancer
; 10(6): 583-592, 2021 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-34950181
14.
Immune-based therapies for hepatocellular carcinoma.
Oncogene
; 39(18): 3620-3637, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32157213
15.
Post-registration experience of nivolumab in advanced hepatocellular carcinoma: an international study.
J Immunother Cancer
; 8(2)2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32868393
16.
Impact of corticosteroid therapy on the outcomes of hepatocellular carcinoma treated with immune checkpoint inhibitor therapy.
J Immunother Cancer
; 8(2)2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33028690
17.
Evaluation of the sensitivity of R1ρ MRI to pH and macromolecular density.
Magn Reson Imaging
; 58: 156-161, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30771445
18.
A molecular and preclinical comparison of the PD-1-targeted T-cell checkpoint inhibitors nivolumab and pembrolizumab.
Semin Oncol
; 44(2): 136-140, 2017 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-28923212
19.
Risk stratification of Barrett's oesophagus using a non-endoscopic sampling method coupled with a biomarker panel: a cohort study.
Lancet Gastroenterol Hepatol
; 2(1): 23-31, 2017 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28404010
20.
Question 1: Is there a role for the ketogenic diet in refractory status epilepticus?
Arch Dis Child
; 103(10): 994-997, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-30104393